SmartPort+^® implantable ports give clinicians dependable, repeated vascular access for IV therapy, medication and fluid delivery, blood sampling, and power-injected Contrast-Enhanced CT (CECT) scanning.

Featuring Endexo^® technology which provides a catheter material more resistant to the accumulation of blood components, and Vortex^® technology to eliminate dead spaces and sludge build up in the port chamber, SmartPort+ is designed to reduce occlusions and thrombosis, reduce overall interventions, and increase department efficiencies.

Why clinicians choose SmartPort+

– Confident CT identification. Smart Angle identifier technology allows CT and CT Low-Profile power-injectable port models to be identified, with the CT engraving visible on chest X-ray or scout scan — helping you confirm power-injectable status quickly at the point of care.

– Designed with patient outcomes in mind. Vortex^® technology is designed for extended device life and is associated with better patient outcomes, fewer complications, less nursing time, and lower costs compared with conventional ports.

– Choice to match clinical need. A range of catheter materials and sizes, placement options, and port body styles gives clinicians more options to suit individual patient anatomy and treatment pathways.

– Indication for use. The SmartPort+^® is indicated for any patient requiring repeated vascular access, for delivery of medications, nutritional supplementation, fluids, blood, blood products, sampling of blood, and power injection of contrast media for imaging.

SmartPort+^® is a trademark of AngioDynamics, Inc. This information is intended for use by healthcare professionals only. Please consult the Instructions for Use (IFU) for full indications, contraindications, warnings, precautions, and risk information prior to use. Kimal PLC is the authorised UK distributor of SmartPort+^® on behalf of AngioDynamics, Inc.